8PT1 image
Entry Detail
PDB ID:
8PT1
Title:
ERK2 covelently bound to RU76 cyclohexenone based inhibitor
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
2023-07-13
Release Date:
2024-07-24
Method Details:
Experimental Method:
Resolution:
1.80 Å
R-Value Free:
0.20
R-Value Work:
0.17
R-Value Observed:
0.18
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Mitogen-activated protein kinase 1
Chain IDs:A
Chain Length:364
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Targeting a key protein-protein interaction surface on mitogen-activated protein kinases by a precision-guided warhead scaffold.
Nat Commun 15 8607 8607 (2024)
PMID: 39366929 DOI: 10.1038/s41467-024-52574-1

Abstact

For mitogen-activated protein kinases (MAPKs) a shallow surface-distinct from the substrate binding pocket-called the D(ocking)-groove governs partner protein binding. Screening of broad range of Michael acceptor compounds identified a double-activated, sterically crowded cyclohexenone moiety as a promising scaffold. We show that compounds bearing this structurally complex chiral warhead are able to target the conserved MAPK D-groove cysteine via reversible covalent modification and interfere with the protein-protein interactions of MAPKs. The electronic and steric properties of the Michael acceptor can be tailored via different substitution patterns. The inversion of the chiral center of the warhead can reroute chemical bond formation with the targeted cysteine towards the neighboring, but less nucleophilic histidine. Compounds bind to the shallow MAPK D-groove with low micromolar affinity in vitro and perturb MAPK signaling networks in the cell. This class of chiral, cyclic and enhanced 3D shaped Michael acceptor scaffolds offers an alternative to conventional ATP-competitive drugs modulating MAPK signaling pathways.

Legend

Protein

Chemical

Disease

Primary Citation of related structures